GET THE APP

Journal of Infectious Diseases & Preventive Medicine

Journal of Infectious Diseases & Preventive Medicine
Open Access

ISSN: 2329-8731

Commentary - (2023)Volume 11, Issue 2

Outbreak of Chickenpox Vaccine

Weng Xue Elsayed*
 
*Correspondence: Weng Xue Elsayed, Department of Infectious Diseases, University of Pisa, Pisa, Italy, Email:

Author info »

Description

Infections with Varicella-Zoster Airus (VZV), a neurotropic alpha viral virus with a double-stranded DNA genome causes chickenpox (varicella). Without any risk factors, chickenpox can lead to life-threatening complications such as bacterial infections, central nervous system symptoms, or even death. Several research have been published that look at the genetic vulnerability to chickenpox. Using an established bioinformatics-based technique, we found global genetic variations that may have contributed to chickenpox susceptibility. To analyze susceptibility genes related with chickenpox, researchers combined data from numerous datasets, including the Genome-Wide Association Studies (GWAS) catalogue, GTEx portal, HaploReg version 4.1, and Ensembl databases.

Particularly, greater expression of the HLA-S, HCG4P5, and ABHD16A genes is associated with increased susceptibility to chickenpox in European, American, and African groups. Europeans, Americans, and Africans had greater allele frequencies of the susceptibility gene extant variations rs9266089, rs10947050, and rs79501286 than Asians. Based on our findings, these genetic variants and related genetic variations may play a crucial role in chickenpox development, with clinical consequences.

Several nations are still considering launching a global chickenpox vaccine programme, however there is no agreement on the most appropriate and effective scheduling of vaccine doses. In Canada, where there are now eight alternative immunization schedules, the chickenpox vaccine schedule dispute is addressed. The goal of this study was to determine the overall efficacy of chickenpox vaccination, along with the particular effects of two distinct vaccine regimens, on chickenpox illness outcomes in Alberta over a 75-year period.

Using an agent-based model of chickenpox disease, researchers looked into the effects of three vaccination scenarios on chickenpox and shingles disease outcomes: baseline (no vaccination), a long dosing interval-Schedule LDI (1st dose-12 months; 2nd dose-4 to 6 years), and a short dosing interval-Schedule SDI (1st dose-12 months; 2nd dose-18 months). Vaccination against chickenpox resulted in a significant reduction in chickenpox incidence in the following 75 years.

Schedule SDI led in a considerably reduced chickenpox incidence, a greater age of chickenpox illness, a lower chickenpox breakout rate, and a longer shingles incidence rate when compared to Schedule LDI.

The consequences of the disease and the efficiency of the vaccination may be impacted by the timing of the vaccine doses, according to our model's findings, which point to the long-term efficacy of the chickenpox vaccine. Nevertheless, the risk of adverse effects, the influence of the schedule on some other antigens in a composition vaccine, parental acceptability, and the expense associated with various schedules are other factors that policymakers who are developing a chickenpox vaccination programme must take into account.

Transient synovitis is one of the numerous uncommon yet unpleasant and self-limiting consequences of chickenpox. This patient experienced transitory synovitis brought on by chickenpox. It was treated with diclofenac sodium suppositories after being diagnosed. To prevent incorrect diagnosis, doctors must be able to link all potential chickenpox complications.

Conclusion

During chickenpox, bacterial complications, in particular skin superinfections, are frequent. Nonetheless, there have only been a very small number of instances of acute bacterial meningitis linked to chickenpox. The majority of the time, they are brought on by Streptococcus pyogenes or Neisseria meningitidis. Researchers report a rare instance of pneumococcal meningitis that struck a 7-year-old kid who had previously been healthy 2 days after developing a chickenpox rash. Researchers made an effort to comprehend the potential pathways leading to bacterial complications during chickenpox, particularly meningitis, based on data from the literature and to identify ways to prevent them.

Author Info

Weng Xue Elsayed*
 
Department of Infectious Diseases, University of Pisa, Pisa, Italy
 

Citation: Elsayed WX (2023) Outbreak of Chickenpox Vaccine. Infect Dis Preve Med. 11:295.

Received: 02-Jan-2023, Manuscript No. JADPR-23-21840; Editor assigned: 04-Jan-2023, Pre QC No. JADPR-23-21840(PQ); Reviewed: 20-Jan-2023, QC No. JADPR-23-21840; Revised: 31-Jan-2023, Manuscript No. JADPR-23-21840(R); Published: 08-Feb-2023 , DOI: 10.35841/2329-8731.22.11.295

Copyright: © 2023 Elsayed WX. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top